Vertical transmission and maternal passive immunity post-SARS-CoV-2
Hanie Karimi1,2, Vahid Mansouri3,2, Nima Rezaei4,2,5
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Future Virology
|October 12, 2023
Summary
This study explores the potential for SARS-CoV-2 (the virus that causes COVID-19) to transmit from mother to baby via placenta or breast milk. It also examines the transfer of maternal antibodies, discussing potential benefits and harms to the fetus or infant.
Area of Science:
- Virology
- Immunology
- Maternal-Fetal Medicine
Background:
- The ongoing COVID-19 pandemic is caused by SARS-CoV-2, a highly contagious virus.
- Vertical transmission (VT) of viruses from mother to child is a known phenomenon for certain pathogens.
- Maternal antibodies are crucial for neonatal immunity, as infants possess underdeveloped immune systems.
Purpose of the Study:
- To investigate the hypothesized vertical transmission of SARS-CoV-2 from mother to fetus/infant.
- To explore the potential transmission of maternal antibodies against SARS-CoV-2 through the placenta and breast milk.
- To discuss the implications of these transmission routes on fetal/infant health, weighing potential benefits against harms.
Main Methods:
- Review of existing literature on SARS-CoV-2 transmission routes.
- Analysis of immunological principles regarding antibody transfer in pregnancy and lactation.
- Hypothetical modeling of SARS-CoV-2 and antibody transmission dynamics.
Main Results:
- While direct SARS-CoV-2 vertical transmission remains under investigation, evidence suggests it is possible.
- Maternal antibodies against SARS-CoV-2 are likely transferred to the fetus/infant via the placenta and breast milk.
- The presence of maternal antibodies may offer some protection but requires further study regarding efficacy and duration.
Conclusions:
- The potential for SARS-CoV-2 vertical transmission necessitates careful consideration for pregnant individuals and newborns.
- Maternal antibody transfer offers a potential protective mechanism, but its net benefit requires comprehensive evaluation.
- Further research is crucial to elucidate the precise mechanisms, risks, and protective effects of SARS-CoV-2 and associated antibodies in the context of vertical transmission.
Keywords:
COVID-19SARS-CoV-2antibodybreast milkimmunitypassive immunityvaccinevertical transmissionvirusMore Related Videos
Related Concept Videos
Development of Immunocompetence
324
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
324
Active versus Passive Immunity
665
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
665
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Infection
8.0K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.0K
Transmission-based Precautions I: Contact, Enteric, and Droplets
3.7K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.7K
Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K


